Q1 FY2027 EarningsQ1 FY27 results significantly beat consensus across the board: revenue $9.76B vs. $9.54B expected, and adjusted EPS $1.45 vs. $1.39 expected. The performance was driven by a robust 30% YoY surge in Electrophysiology Therapies (EPT) following the pulsed field ablation portfolio launch and an extra week in the quarter contributing ~$570M. Free cash flow of $1.29B beat the $1.87B annual run-rate floor implicitly, despite heavy acquisition activity, reinforcing a strong start to the 53-week fiscal year.
Financial report interval: 2026.05.01 - 2026.07.31
Overview: Medtronic(MDT) the Revenue is 9.756 B (+14.25%), Beat estimate;the EBIT is 2.316 B (+14.88%), Beat estimate;the EPS is 1.14 (+40.74%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
9.76B14.25%
9.54B11.78%
+0.21B2.47%
EBITExceed expectations
2.32B14.88%
2.26B12.24%
+0.05B2.64%
EPSExceed expectations
1.1440.74%
1.000223.48%
+0.139817.26%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf